Company

Revalia Bio, Inc.

Revalia Bio uses data from donated human organs to support drug development.

About

Revalia Bio operates a Human Data Trials platform that uses data from donated, perfused human organs to assess drug candidates before clinical trials. It serves biopharma teams, health systems, and researchers. Based in New Haven, US, the company raised USD 14.5 mn in Seed funding on September 4, 2025, co-led by America's Frontier Fund and Sierra Ventures.

1Funding rounds

2Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in